MCID: HRP004
MIFTS: 54

Herpes Zoster

Categories: Skin diseases, Infectious diseases

Aliases & Classifications for Herpes Zoster

MalaCards integrated aliases for Herpes Zoster:

Name: Herpes Zoster 12 51 52 3 42 14
Shingles 12 51 41 3
Herpes Zoster Disease 69
Herpes Zona 12

Classifications:



External Ids:

Disease Ontology 12 DOID:8536
ICD10 33 B02 B02.9
ICD9CM 35 053
MeSH 42 D006562
NCIt 47 C71079
UMLS 69 C0019360

Summaries for Herpes Zoster

MedlinePlus : 41 shingles is a disease caused by the varicella-zoster virus - the same virus that causes chickenpox. after you have chickenpox, the virus stays in your body. it may not cause problems for many years. as you get older, the virus may reappear as shingles. although it is most common in people over age 50, anyone who has had chickenpox is at risk. you can't catch shingles from someone who has it. however, if you have a shingles rash, you can pass the virus to someone who has never had chickenpox. this would usually be a child, who could get chickenpox instead of shingles. the virus spreads through direct contact with the rash, and cannot spread through the air. early signs of shingles include burning or shooting pain and tingling or itching, usually on one side of the body or face. the pain can be mild to severe. rashes or blisters appear anywhere from one to 14 days later. if shingles appears on your face, it may affect your vision or hearing. the pain of shingles may last for weeks, months, or even years after the blisters have healed. there is no cure for shingles. early treatment with medicines that fight the virus may help. these medicines may also help prevent lingering pain. a vaccine may prevent shingles or lessen its effects. the vaccine is recommended for people 60 or over. in some cases doctors may give it to people ages 50 to 59. nih: national institute of allergy and infectious diseases

MalaCards based summary : Herpes Zoster, also known as shingles, is related to myelitis and aseptic meningitis, and has symptoms including angina pectoris, back pain and exanthema. An important gene associated with Herpes Zoster is DPYD (Dihydropyrimidine Dehydrogenase), and among its related pathways/superpathways are Cytokine Signaling in Immune system and Toll-like Receptor Signaling Pathway. The drugs Foscarnet and Ketorolac have been mentioned in the context of this disorder. Affiliated tissues include skin, eye and bone.

CDC : 3 Almost 1 out of every 3 people in the United States will develop shingles, also known as zoster or herpes zoster, in their lifetime. There are an estimated 1 million cases of shingles each year in this country. Anyone who has recovered from chickenpox may develop shingles; even children can get shingles. However the risk of shingles increases as you get older. About half of all cases occur in men and women 60 years old or older…

NINDS : 51 Shingles (herpes zoster) is an outbreak of rash or blisters on the skin that is caused by the same virus that causes chickenpox — the varicella-zoster virus. The first sign of shingles is often burning or tingling pain (which can be severe), or sometimes numbness or itch,generally on one side of the body. After several days or a week, a rash of fluid-filled blisters, similar to chickenpox, appears in one area on one side of the body. Shingles pain can be mild or intense.  Some people have mostly itching; some feel pain from the gentlest touch or breeze.  The most common location for shingles is a band, called a dermatome, spanning one side of the trunk around the waistline. Anyone who has had chickenpox is at risk for shingles.  Scientists think that some of the virus particles from the original exposure to the varicella-zoster virus,leave the skin blisters and move into the nervous system.  When the varicella-zoster virus reactivates, the virus moves back down the long nerve fibers that extend from the sensory cell bodies to the skin.  The viruses multiply, the tell-tale rash erupts, and the person now has shingles.

Disease Ontology : 12 A viral infectious disease that results_in infection located in nerve fiber, has material basis in Human herpesvirus 3, which reactivates after appearing as chickenpox in childhood. The virus is transmitted_by direct contact with the rash, which can develop into chickenpox in newly-infected individuals. The infection has symptom rash which is followed by blisters, has symptom headache, has symptom fever, has symptom malaise, has symptom itching, has symptom burning pain, and has symptom paresthesia.

Wikipedia : 72 Shingles, also known as herpes zoster, is a viral disease characterized by a painful skin rash with... more...

Related Diseases for Herpes Zoster

Diseases related to Herpes Zoster via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 337)
id Related Disease Score Top Affiliating Genes
1 myelitis 30.1 HLA-B IFNG IL10 IL2
2 aseptic meningitis 29.9 HLA-A HLA-B
3 rheumatoid arthritis 29.9 HLA-B IFNG IL10 IL2
4 lymphoma 28.9 COL17A1 IFNG IL10 IL2 TRPV1
5 geniculate herpes zoster 12.5
6 herpes zoster ophthalmicus 12.4
7 postherpetic neuralgia 11.7
8 eye accommodation disease 10.6 IFNG IL10
9 thelaziasis 10.6 IFNG IL10
10 autoimmune inner ear disease 10.6 IFNG TRPV1
11 dumping syndrome 10.6 IFNG IL10
12 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids 10.6 IFNG IL10
13 aids wasting syndrome 10.6 IFNA2 IL10
14 gerstmann syndrome 10.6 IFNG IL10
15 reese retinal dysplasia 10.6 IFNA2 IL2
16 centronuclear myopathy 5 10.6 IFNG IL10
17 strawberry gallbladder 10.5 IFNG IL10
18 oropharyngeal cancer, childhood 10.5 IFNG IL10
19 bulbospinal polio 10.5 IFNG IL2
20 autoimmune polyglandular syndrome type 3 10.5 IFNG IL2
21 autosomal recessive severe congenital neutropenia due to cxcr2 deficiency 10.5 HLA-A HLA-B
22 anthracosilicosis 10.5 IFNG IL2
23 x-linked intellectual disability, van esch type 10.4 IFNG IL2
24 ramsay hunt syndrome i 10.4 HLA-A HLA-B
25 herpangina 10.4 IFNG IL10
26 myopia 25, autosomal dominant 10.4 IL10 IL2
27 disease of mental health 10.4 HLA-B IFNG IL10
28 cardioskeletal syndrome, kuwaiti type 10.4 HLA-A HLA-B
29 cornea cancer 10.4 HLA-B IFNG IL10
30 lens-induced iridocyclitis 10.4 HLA-A HLA-B
31 tonsil cancer 10.4 IFNG IL10
32 myeloid and lymphoid neoplasms with eosinophilia and abnormalities of pdgfra, pdgfrb, and fgfr1 10.4 HLA-B IFNG
33 amyotrophic lateral sclerosis type 10 10.4 IFNG IL2
34 tinea favosa 10.4 IL2 TRPV1
35 hernia of ovary and fallopian tube 10.4 HLA-A HLA-B
36 respiratory system disease 10.4 HLA-B IFNG IL10
37 progressive myoclonus epilepsy 10.4 HLA-A HLA-B
38 spindle cell hemangioma 10.3 FCGR3A IFNG IL10
39 thrombotic thrombocytopenic purpura 10.3 HLA-A HLA-B
40 endometrial clear cell adenocarcinoma 10.3 IFNG IL10 TRPV1
41 bacterial gastritis 10.3 IFNG IL10 TRPV1
42 acute chest syndrome 10.3 IFNG IL10 TRPV1
43 lymphocytic colitis 10.3 IFNG IL2
44 mediastinum neurofibroma 10.3 IFNG IL10 TRPV1
45 tuberculum sellae meningioma 10.3 IFNG IL10 TRPV1
46 heterotaxy, visceral, 4, autosomal 10.3 HLA-A HLA-B
47 not otherwise specified 3-mga-uria type 10.3 HLA-A HLA-B
48 prostate carcinoma in situ 10.3 IFNG IL10 TRPV1
49 parametritis 10.3 IFNG IL2
50 papillary squamous carcinoma 10.3 IFNG IL10

Graphical network of the top 20 diseases related to Herpes Zoster:



Diseases related to Herpes Zoster

Symptoms & Phenotypes for Herpes Zoster

UMLS symptoms related to Herpes Zoster:


angina pectoris, back pain, exanthema, fever, headache, pain, pruritus, sciatica, seizures, syncope, tremor, chronic pain, vertigo/dizziness, equilibration disorder, sleeplessness

Drugs & Therapeutics for Herpes Zoster

Drugs for Herpes Zoster (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 366)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Foscarnet Approved Phase 4 63585-09-1, 4428-95-9 3415
2
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
3
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 83-43-2 6741
4
Nepafenac Approved Phase 4 78281-72-8 151075
5
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-24-8 5755
6
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
7
Capsaicin Approved Phase 4,Phase 3,Phase 2 404-86-4 1548943
8
Ethanol Approved Phase 4 64-17-5 702
9
Budesonide Approved Phase 4 51333-22-3 63006 5281004
10
Adalimumab Approved Phase 4 331731-18-1 16219006
11
Methotrexate Approved Phase 4,Phase 3,Phase 2 1959-05-2, 59-05-2 126941
12
Tofacitinib Approved, Investigational Phase 4,Phase 2 477600-75-2
13
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 3,Phase 2 148553-50-8 5486971
14
Gabapentin Approved, Investigational Phase 4,Phase 3,Phase 2 60142-96-3 3446
15
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2 59-30-3 6037
16
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2 58-05-9 143 6006
17
Phosphonoacetic Acid Experimental Phase 4 4408-78-0 546
18
gamma-Aminobutyric acid Investigational Phase 4,Phase 3 56-12-2 119
19 Acyclovir Phase 4,Phase 3,Phase 2,Phase 1
20 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
21 Anti-Retroviral Agents Phase 4,Phase 3,Phase 1
22 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1
23 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2
24 Reverse Transcriptase Inhibitors Phase 4,Phase 3
25 Vaccines Phase 4,Phase 2,Phase 3,Phase 1
26 Analgesics Phase 4,Phase 3,Phase 2,Phase 1
27 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 3,Phase 1
28 Antiemetics Phase 4,Phase 3,Phase 2,Phase 1
29 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1
30 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 3,Phase 1
31 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Phase 1
32 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1
33 Autonomic Agents Phase 4,Phase 3,Phase 2,Phase 1
34 Cyclooxygenase Inhibitors Phase 4,Phase 3,Phase 1
35 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1
36 glucocorticoids Phase 4,Phase 3,Phase 2,Phase 1
37 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
38 Hormones Phase 4,Phase 3,Phase 2,Phase 1
39 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
40 Ketorolac Tromethamine Phase 4
41 Methylprednisolone acetate Phase 4,Phase 3,Phase 2
42 Methylprednisolone Hemisuccinate Phase 4,Phase 3,Phase 2
43 Neuroprotective Agents Phase 4,Phase 3,Phase 2
44 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1
45 Prednisolone acetate Phase 4,Phase 3,Phase 2
46 Prednisolone hemisuccinate Phase 4,Phase 3,Phase 2
47 Prednisolone phosphate Phase 4,Phase 3,Phase 2
48 Protective Agents Phase 4,Phase 3,Phase 2
49 Cyclooxygenase 2 Inhibitors Phase 4
50 Antipruritics Phase 4,Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 454)

id Name Status NCT ID Phase Drugs
1 Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes Zoster Unknown status NCT02151240 Phase 4 Foscarnet Sodium;Acyclovir
2 Study on Effectiveness of 2-dose Live Attenuated Varicella Vaccine Unknown status NCT02146469 Phase 4
3 The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination Unknown status NCT01866566 Phase 4
4 Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney Transplantation Unknown status NCT00940940 Phase 4
5 Effect of Anti-inflammatory Topical Prednisolone, Nepafenac and Ketorolac in Intra-operative Mydriasis in Facetectomies Unknown status NCT00865540 Phase 4 prednisolone acetate 1%;ketorolac tromethamine 0.4%;nepafenac 0.1%;methylcellulose 0.5%
6 Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain Unknown status NCT01264237 Phase 4 Etoricoxib;Placebo
7 Qutenza for Critical Ischaemia in End Stage Renal Failure Unknown status NCT01704339 Phase 4 QUTENZA
8 Olive Oil's Cream Effectiveness in Prevention of Pressure Ulcers in Immobilized Patients in Primary Care Unknown status NCT01595347 Phase 4 Hyper-oxigenated fatty acid
9 T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020 Completed NCT01911065 Phase 4
10 Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine Completed NCT02173899 Phase 4
11 Safety of a Second Dose of Biken's Varicella Vaccine Completed NCT00830648 Phase 4
12 A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster Completed NCT02152800 Phase 4 valacyclovir hydrocholoride
13 ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034) Completed NCT01556451 Phase 4
14 Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin Completed NCT01684072 Phase 4
15 Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine Completed NCT01817270 Phase 4
16 Zostavax® at Minimum Release Specification Approaching Expiry (V211-044) Completed NCT00681031 Phase 4
17 Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine Completed NCT01815073 Phase 4
18 Varicella Vaccination With Pulmicort Completed NCT00641446 Phase 4 budesonide;varicella zoster virus
19 The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children Completed NCT01138215 Phase 4
20 Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™ Completed NCT02958345 Phase 4
21 ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020) Completed NCT00550745 Phase 4
22 Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant Psoriasis Completed NCT01356004 Phase 4 live attenuated chicken pox vaccine;saline, efficacy
23 MMR and Varicella Vaccine in Premature Infants Completed NCT00156559 Phase 4
24 Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067) Completed NCT00312858 Phase 4
25 Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases Completed NCT00126997 Phase 4
26 Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) Completed NCT00326183 Phase 4
27 Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza Completed NCT01693380 Phase 4
28 Palatability Testing of a New Paediatric Formulation of Valacyclovir Completed NCT01682109 Phase 4 Valacyclovir
29 Safety Study of a Refrigerator-stable Formulation of VARIVAX® Completed NCT00432731 Phase 4
30 An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate Completed NCT02187055 Phase 4 Tofacitinib with methotrexate;Tofacitinib without methotrexate
31 MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine Completed NCT02225327 Phase 4
32 Pregabalin in the Treatment of Essential Tremor Completed NCT00646451 Phase 4 pregabalin;placebo capsules
33 Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years Completed NCT02215863 Phase 4
34 Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV Completed NCT00329251 Phase 4
35 Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD) Completed NCT00760747 Phase 4 Atomoxetine
36 Safety and Tolerability of Herpes Zoster Vaccine Rheumatologic Patients Recruiting NCT03016884 Phase 4
37 Zoster Eye Disease Study Recruiting NCT03134196 Phase 4 Masked Placebo;Masked Oral Valacyclovir
38 Acupuncture in Herpes Zoster Neuralgia (ACUZoster) Recruiting NCT00885586 Phase 4 gabapentine
39 Immune Response to Shingles Vaccination Recruiting NCT02624375 Phase 4 Zoster Vaccine Live
40 Safety and Immunogenicity of a Zoster Vaccine in SLE Recruiting NCT02477150 Phase 4
41 "Equistasi" and Gait in Hemiparesis Recruiting NCT02714478 Phase 4
42 VAXCHORA Pediatric Study Recruiting NCT03220737 Phase 4
43 Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus Vaccine Active, not recruiting NCT02514018 Phase 4
44 Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Children Active, not recruiting NCT01982409 Phase 4
45 The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose Vaccination Enrolling by invitation NCT01830283 Phase 4
46 Immunodeficiency in Cartilage-hair Hypoplasia: Sub-project on Safety of Vaccination Against Chickenpox Enrolling by invitation NCT02383797 Phase 4
47 Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine Not yet recruiting NCT02026089 Phase 4
48 ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors Not yet recruiting NCT02444936 Phase 4 ZOSTAVAX
49 Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy Terminated NCT02408159 Phase 4 Varicella Zoster Vaccine;Placebo
50 Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines Terminated NCT00138255 Phase 4

Search NIH Clinical Center for Herpes Zoster

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: herpes zoster

Genetic Tests for Herpes Zoster

Anatomical Context for Herpes Zoster

MalaCards organs/tissues related to Herpes Zoster:

39
Skin, Eye, Bone, Testes, Brain, Kidney, Liver

Publications for Herpes Zoster

Articles related to Herpes Zoster:

(show top 50) (show all 1268)
id Title Authors Year
1
In vivo confocal microscopy detects bilateral changes of corneal immune cells and nerves in unilateral herpes zoster ophthalmicus. ( 28923503 )
2017
2
Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy. ( 28845604 )
2017
3
Prognostic value of Hutchinson's sign for ocular involvement in herpes zoster ophthalmicus. ( 28422437 )
2017
4
Risk and impact of herpes zoster on patients with diabetes: a population-based study, 2009-2014. ( 28933622 )
2017
5
Comparing serum microRNA levels of acute herpes zoster patients with those of postherpetic neuralgia patients. ( 28225487 )
2017
6
Gentiana scabra Bunge. Formula for Herpes Zoster: Biological Actions of Key Herbs and Systematic Review of Efficacy and Safety. ( 28078812 )
2017
7
Herpes Zoster as a Risk Factor for Incident Giant Cell Arteritis. ( 28853238 )
2017
8
Keratitis in association with herpes zoster and varicella vaccines. ( 28837183 )
2017
9
Pediatric vaccine-strain herpes zoster: a case series. ( 28944968 )
2017
10
Herpes Zoster Ophthalmicus with Orbital Apex Syndrome-Difference in Outcomes and Literature Review. ( 28622058 )
2017
11
Rheumatoid arthritis: Reducing the risk of herpes zoster. ( 28905860 )
2017
12
Shoulder pain due to cervical radiculopathy: an underestimated long-term complication of herpes zoster virus reactivation? ( 28798978 )
2017
13
Rapid diagnosis of herpes zoster by loop-mediated isothermal amplification in a pregnant woman showing folliculitis-like eruption without vesicles. ( 28488349 )
2017
14
Orbital cellulitis due to ophthalmic herpes zoster in an immunocompetent child: A case report. ( 28802683 )
2017
15
Association of cigarette smoking with a past history and incidence of herpes zoster in the general Japanese population: the SHEZ Study. ( 28091339 )
2017
16
Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia. ( 28057661 )
2017
17
Successful Treatment of Brachial Plexopathy Due to Herpes Zoster Infection With Intravenous Immunoglobulin. ( 27879550 )
2017
18
Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia. ( 28086817 )
2017
19
Prevaccination epidemiology of herpes zoster in Denmark: Quantification of occurrence and risk factors. ( 28874322 )
2017
20
Local Brain Activity Differences Between Herpes Zoster and Postherpetic Neuralgia Patients: A Resting-State Functional MRI Study. ( 28727713 )
2017
21
Disseminated herpes zoster causing acute respiratory distress syndrome in an immunocompetent patient. ( 28942398 )
2017
22
Hospitalizations realted to herpes zoster infection in the Canary Islands, Spain (2005-2014). ( 28836951 )
2017
23
Clinical characteristics of headache or facial pain prior to the development of acute herpes zoster of the head. ( 27978460 )
2017
24
Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis. ( 28895088 )
2017
25
Herpes zoster incidence and cost in patients receiving autologous hematopoietic stem-cell transplant. ( 28945107 )
2017
26
Improvement in Herpes Zoster Vaccination in Patients with Rheumatoid Arthritis: A Quality Improvement Project. ( 28042124 )
2017
27
Rapid development of cutaneous melanoma metastases after herpes zoster infection in a radiotherapy field. ( 28940227 )
2017
28
Rare case of herpes zoster ophthalmicus with orbital myositis, oculomotor nerve palsy and anterior uveitis. ( 28195080 )
2017
29
Consecutive occurrence of isotopic and isomorphic response in a patient: Patchy granuloma annulare arising in the site of herpes zoster scar and seborrhoeic dermatitis. ( 28670742 )
2017
30
Pulsed Radiofrequency to the Dorsal Root Ganglion in Acute Herpes Zoster and Postherpetic Neuralgia. ( 28339440 )
2017
31
Editorial: Herpes Zoster: Fear the Infection, Value the Solution. ( 28845573 )
2017
32
Effect of Zhuang medicine medicated thread moxibustion on protomics in serum of postherpetic neuralgia patient with Herpes zoster. ( 28671082 )
2017
33
Herpes zoster-related aseptic meningitis and encephalomeningitis: A single faculty retrospective case study. ( 28557114 )
2017
34
Comparison of efficacy of continuous epidural block and pulsed radiofrequency to the dorsal root ganglion for management of pain persisting beyond the acute phase of herpes zoster. ( 28827823 )
2017
35
Temporal Association of Herpes Zoster Eruption Post-Aminolevulinic Acid Hydrochloride Photodynamic Therapy for Actinic Keratoses. ( 28809998 )
2017
36
Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults a8Y50A years of age with a prior history of herpes zoster: a phase III, non-randomized, open-label clinical trial. ( 28068212 )
2017
37
Severe atypical herpes zoster as an initial symptom of fatal myelodysplastic syndrome with refractory anemia and blast excess (RAEB II). ( 28652792 )
2017
38
Increased risk of herpes zoster in patients with psoriasis: A population-based retrospective cohort study. ( 28829784 )
2017
39
A case of herpes zoster ophthalmicus preceded one week by diplopia and ophthalmalgia. ( 28367946 )
2017
40
Orbital apex syndrome as a complication of herpes zoster ophthalmicus. ( 28237946 )
2017
41
Herpes zoster in kidney transplant recipients: protective effect of anti-cytomegalovirus prophylaxis and natural killer cell count. A single-center cohort study. ( 28940695 )
2017
42
Herpes zoster ophthalmicus and strabismus: a unique cause of secondary Brown syndrome. ( 28625469 )
2017
43
Serum C-Reactive Protein and Congestive Heart Failure as Significant Predictors of Herpes Zoster Vaccine Response in Elderly Nursing Home Residents. ( 28838148 )
2017
44
Risk Factors for Aseptic Meningitis in Herpes Zoster Patients. ( 28566903 )
2017
45
Complex Regional Pain Syndrome following an Episode of Herpes Zoster: A Case Report. ( 28819596 )
2017
46
Localized hypohidrosis is an unrecognized sequela of herpes zoster. ( 27986141 )
2017
47
Discoid lupus erythematosus occurring in an area previously affected by herpes zoster virus: Wolf's isotopic reaction? ( 27976613 )
2016
48
Pain, Itch, Quality of Life, and Costs after Herpes Zoster. ( 27611885 )
2016
49
Herpes Zoster Infection Involving Mandibular Division of Trigeminal Nerve and Ramsay Hunt Syndrome with Meningitis in an Immunocompetent Patient: A Rare Association. ( 27504334 )
2016
50
Hard Palate Lesion due to Herpes Zoster Virus Infection. ( 27629983 )
2016

Variations for Herpes Zoster

Expression for Herpes Zoster

Search GEO for disease gene expression data for Herpes Zoster.

Pathways for Herpes Zoster

Pathways related to Herpes Zoster according to GeneCards Suite gene sharing:

(show all 27)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.19 HLA-A HLA-B IFNA2 IFNG IL10 IL2
2
Show member pathways
12.7 IFNA2 IFNG IL10 IL2
3
Show member pathways
12.65 HLA-A HLA-B IFNA2 IFNG IL2
4
Show member pathways
12.47 HLA-A HLA-B IFNA2 IFNG IL10 IL2
5
Show member pathways
12.38 HLA-A HLA-B IFNA2 IFNG
6 12.16 HLA-A HLA-B IFNG IL10
7 12.08 FCGR3A IFNA2 IFNG IL10
8
Show member pathways
12.03 IFNA2 IFNG IL10 IL2
9 11.98 FCGR3A HLA-A HLA-B
10 11.92 FCGR3A HLA-A HLA-B
11
Show member pathways
11.91 FCGR3A HLA-A HLA-B IFNA2 IFNG IL2
12
Show member pathways
11.83 HLA-A IFNG IL2
13
Show member pathways
11.8 IFNG IL10 IL2
14 11.74 IFNA2 IFNG IL10 IL2
15 11.68 IFNA2 IFNG IL10 IL2
16 11.66 IFNG IL10 IL2
17
Show member pathways
11.53 HLA-A IFNG IL2
18 11.4 GYPC IFNG IL10
19 11.36 IFNG IL10 IL2
20 11.34 IFNA2 IFNG IL10 IL2
21
Show member pathways
11.31 HLA-A HLA-B IFNA2 IFNG IL10 IL2
22
Show member pathways
11.23 IFNG IL10 IL2
23 11.22 HLA-B IFNA2 IFNG
24 11.08 IFNG IL2
25 11.06 IFNG IL10 IL2
26 11.03 HLA-A HLA-B
27 10.91 IFNG IL10 IL2

GO Terms for Herpes Zoster

Cellular components related to Herpes Zoster according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 integral component of lumenal side of endoplasmic reticulum membrane GO:0071556 8.96 HLA-A HLA-B
2 MHC class I protein complex GO:0042612 8.62 HLA-A HLA-B

Biological processes related to Herpes Zoster according to GeneCards Suite gene sharing:

(show all 15)
id Name GO ID Score Top Affiliating Genes
1 interferon-gamma-mediated signaling pathway GO:0060333 9.61 HLA-A HLA-B IFNG
2 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.58 IFNA2 IFNG IL2
3 antigen processing and presentation of peptide antigen via MHC class I GO:0002474 9.55 HLA-A HLA-B
4 defense response to protozoan GO:0042832 9.54 IFNG IL10
5 type I interferon signaling pathway GO:0060337 9.54 HLA-A HLA-B IFNA2
6 positive regulation of peptidyl-serine phosphorylation of STAT protein GO:0033141 9.52 IFNA2 IFNG
7 negative regulation of growth of symbiont in host GO:0044130 9.51 IFNG IL10
8 positive regulation of isotype switching to IgG isotypes GO:0048304 9.49 IFNG IL2
9 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent GO:0002480 9.48 HLA-A HLA-B
10 positive regulation of MHC class II biosynthetic process GO:0045348 9.46 IFNG IL10
11 antigen processing and presentation GO:0019882 9.43 HLA-A HLA-B IFNG
12 immune response GO:0006955 9.43 FCGR3A HLA-A HLA-B IFNG IL10 IL2
13 protection from natural killer cell mediated cytotoxicity GO:0042270 9.32 HLA-A HLA-B
14 sensory perception of mechanical stimulus GO:0050954 9.16 IFNG TRPV1
15 regulation of immune response GO:0050776 9.02 COL17A1 FCGR3A HLA-A HLA-B IFNG

Molecular functions related to Herpes Zoster according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 peptide antigen binding GO:0042605 8.96 HLA-A HLA-B
2 cytokine activity GO:0005125 8.92 IFNA2 IFNG IL10 IL2

Sources for Herpes Zoster

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....